BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Should YOU Be Taking BPC 157 Peptides? Dr Brad Stanfield PEPTIDES: THE 2026 FDA CRACKDOWN CONTROVERSYWhy this is MASSIVE SEO RIGHT NOW BPC 157 banned BPC 157: Experimental Peptide Creates Risk for Athletes An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica